Compare TARA & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | LTRX |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 237.4M |
| IPO Year | 2014 | 2000 |
| Metric | TARA | LTRX |
|---|---|---|
| Price | $5.11 | $5.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $21.67 | $6.50 |
| AVG Volume (30 Days) | ★ 673.0K | 613.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $122,923,000.00 |
| Revenue This Year | N/A | $1.12 |
| Revenue Next Year | N/A | $15.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $1.91 |
| 52 Week High | $7.82 | $8.24 |
| Indicator | TARA | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 44.09 |
| Support Level | $4.95 | $5.09 |
| Resistance Level | $5.39 | $5.73 |
| Average True Range (ATR) | 0.29 | 0.39 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 44.93 | 27.92 |
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.